墨西哥的儿童白血病:朝着实施CAR-T细胞治疗计划的方向
Juan Carlos Bustamante-Ogando1, Alejandrina Hernández-López2,3, César Galván-Díaz4
1Immunodeficiencies Research Laboratory and Clinical Immunology Department, Instituto Nacional de Pediatría, Mexico City, Mexico.
Frontiers in oncology
|February 2, 2024
概括
儿童白血病在世界各地很常见,CAR-T细胞疗法为耐火病例提供了有前途的治疗方法. 目前正在努力改善全球接入,特别是在墨西哥,复发或耐药性疾病的发病率较高.
科学领域:
- 儿科瘤学 儿科瘤学
- 血液学的恶性瘤
- 细胞和基因疗法细胞和基因疗法
背景情况:
- 白血病是全球最常见的儿科癌症,对耐火病例的预后有所改善,但仍然具有挑战性.
- 化学疗法等传统治疗方法是有效的,但新的策略,如免疫疗法,包括CAR-T细胞,对于复发性或耐药性疾病至关重要.
- 卡特-T细胞疗法已经证明了临床疗效,并获得了监管批准,但全球可访问性仍然是一个重大问题,特别是在低收入和中等收入国家.
研究的目的:
- 为了提供墨西哥儿童白血病的概述.
- 讨论当前的策略,进步和挑战,使细胞和基因疗法可用于墨西哥白血病患者.
- 突出正在进行的努力,以改善墨西哥患者获得CAR-T细胞治疗的机会.
主要方法:
- 关于儿童白血病治疗和免疫治疗的当前文献的综述.
- 分析墨西哥白血病诊断和治疗的情况.
- 探索在墨西哥实施CAR-T细胞等先进疗法的战略和挑战.
主要成果:
- 儿童白血病约占墨西哥儿童癌症的50%.
- 与国际报告相比,墨西哥的复发性或耐药性白血病的发病率更高.
- 在白血病治疗方面取得了重大进展,墨西哥患者的细胞和基因疗法在地平线上.
结论:
- 让像CAR-T细胞疗法这样的先进疗法成为墨西哥患者的首要任务.
- 正在进行的努力旨在克服挑战,并改善墨西哥儿童白血病的基因和细胞疗法的可用性.
- 解决复发/耐药性疾病发病率较高的多因素问题对于改善结果至关重要.
相关概念视频
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.